MNMifa Nurfadilah

Mifa Nurfadilah

*This is an algorithmically generated author record based on publicly available information.

Mifa Nurfadilah has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Environmental enteric dysfunction influences linear growth of children through insulin-like growth factor-1: findings from the Indonesian Action Against Stunting Hub birth cohort

    by Min Kyaw Htet, Mifa Nurfadilah, Tiffany C. Angelin, Benjamin Momo Kadia, Isobel L. Gabain, Anouschka S. Ramsteijn, Hilary Davies-Kershaw, Beatriz Calvo-Urbano, Joanne P. Webster, Alan W. Walker, et al.

    Poor gut health, characterized by persistent immune activation and increased intestinal permeability, is considered a significant underlying cause of impaired child growth. This study aimed to investigate effects of environmental enteric dysfunction (EED) and systemic inflammation on plasma insulin-like growth factor (IGF)-1 and linear growth among Indonesian infants. In this longitudinal cohort study (Action Against Stunting Hub), faecal and plasma samples were collected at six months of age, and anthropometry assessment was conducted at six and twelve months of age. EED markers included faecal myeloperoxidase, alpha-1 antitrypsin and plasma intestinal fatty acid binding protein (IFABP). Systemic inflammation markers included C-reactive protein, alpha-1 acid glycoprotein and cluster of differentiation-14 (CD14). IGF-1 was measured as a growth biomarker. Correlation and multivariable regression analyses assessed association with length-for-age z-score (LAZ). Structural equation modelling explored potential pathways. Elevated EED markers were common among the infants (>80%). Maternal height, birth weight and IGF-1 were significant determinants of LAZ at 12 months. Pathway analysis showed IGF-1 was negatively associated with CD14, whereas CD14 was positively associated with IFABP. EED influences linear growth indirectly through systemic inflammation and altered growth signalling. Studies to further address gut integrity and systemic inflammation to improve linear growth are recommended. This article is part of the theme issue ‘Biological, biomedical and environmental drivers of stunting’.


  • Open Access

    Exploring the diet–microbiome–growth axis among under-2-year-old children: a case–control study in East Lombok, Indonesia

    by Min Kyaw Htet, Mifa Nurfadilah, Anouschka S. Ramsteijn, Tiffany C. Angelin, Amanda S. Ameline, Benjamin Momo Kadia, Isobel L. Gabain, Hilary Davies-Kershaw, Beatriz Calvo-Urbano, Joanne P. Webster, et al.

    Previous studies have compared the microbiota profiles of stunted and non-stunted children. However, how these profiles interact with dietary patterns is not completely understood. To assess differences in microbial diversity, composition and bacteria taxa between stunted and non-stunted children and how the consumption of food groups influence the gut microbiota of stunted children, this matched case–control study was conducted among 150 pairs of stunted and non-stunted children of between 18–23 months old in East Lombok, Indonesia. Anthropometry and dietary data were collected by trained enumerators. Microbiome data were generated by sequencing the V4 hypervariable region of the 16S rRNA gene. No between-group differences in alpha and beta diversity were observed. Exploratory analysis identified that Agathobacter, Coprococcus, Dorea, Hominimerdicola, Lawsonibacter and Ruminococcoides were more proportionally abundant among non-stunted children and Peptostreptococcus among stunted children. However, there was no association between food group consumption and abundance of these taxa. Breastfeeding significantly shaped the microbiota profiles. Future research on the association between microbiota profiles and complementary feeding should incorporate approaches such as diet modelling to capture the combined contributions of food groups and dietary components, alongside longitudinal study designs. This article is part of the theme issue ‘Biological, biomedical and environmental drivers of stunting’.